The current assessment of PGL metastatic potential relies on a comprehensive evaluation of several factors, including tumor size (≥5 cm), the presence of an SDHB mutation, a dopaminergic phenotype, and a high Ki-67 index. This evidence concerns the gene MKI67 and neoplasm.